Mastronardi C A, Walczewska A, Yu W H, Karanth S, Parlow A F, McCann S M
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808-4124, USA.
Proc Soc Exp Biol Med. 2000 Jul;224(3):152-8. doi: 10.1046/j.1525-1373.2000.22414.x.
In humans there is a circadian rhythm of leptin concentrations in plasma with a minimum in the early morning and a maximum in the middle of the night. By taking blood samples from adult male rats every 3 hr for 24 hr, we determined that a circadian rhythm of plasma leptin concentrations also occurs in the rat with a peak at 0130h and a minimum at 0730h. To determine if this rhythm is controlled by nocturnally released hormones, we evaluated the effect of hormones known to be released at night in humans, some of which are also known to be released at night in rats. In humans, prolactin (PRL), growth hormone (GH), and melatonin are known to be released at night, and adrenocorticotropic hormone (ACTH) release is inhibited. In these experiments, conscious rats were injected intravenously with 0.5 ml diluent or the substance to be evaluated just after removal of the first blood sample (0.3 ml), and additional blood samples (0.3 ml) were drawn every 10 min thereafter for 2 hr. The injection of highly purified sheep PRL (500 microg) produced a rapid increase in plasma leptin that persisted for the duration of the experiment. Lower doses were ineffective. To determine the effect of blockade of PRL secretion on leptin secretion, alpha bromoergocryptine (1.5 mg), a dopamine-2-receptor agonist that rapidly inhibits PRL release, was injected. It produced a rapid decline in plasma leptin within 10 min, and the decline persisted for 120 min. The minimal effective dose of GH to lower plasma leptin was 1 mg/rat. Insulin-like growth factor (IGF-1) (10 microg), but not IGF-2 (10 microg), also significantly decreased plasma leptin. Melatonin, known to be nocturnally released in humans and rats, was injected at a dose of 1 mg/rat during daytime (1100h) or nighttime (2300h). It did not alter leptin release significantly. Dexamethasone (DEX), a potent glucocorticoid, was ineffective at a 0. 1-mg dose but produced a delayed, significant increase in leptin, manifest 100-120 min after injection of a 1 mg dose. Since glucocorticoids decrease at night in humans at the time of the maximum plasma concentrations of leptin, we hypothesize that this increase in leptin from a relatively high dose of DEX would mimic the response to the release of corticosterone following stress in the rat and that glucocorticoids are not responsible for the circadian rhythm of leptin concentration. Therefore, we conclude that an increase in PRL secretion during the night may be responsible, at least in part, for the nocturnal elevation of leptin concentrations observed in rats and humans.
在人类中,血浆中瘦素浓度存在昼夜节律,清晨时浓度最低,午夜时浓度最高。通过在24小时内每隔3小时从成年雄性大鼠采集血样,我们确定大鼠血浆瘦素浓度也存在昼夜节律,在0130时达到峰值,0730时降至最低。为了确定这种节律是否受夜间释放的激素控制,我们评估了已知在人类夜间释放的激素的作用,其中一些激素在大鼠中也已知在夜间释放。在人类中,催乳素(PRL)、生长激素(GH)和褪黑素在夜间释放,促肾上腺皮质激素(ACTH)释放受到抑制。在这些实验中,清醒的大鼠在采集第一份血样(0.3 ml)后立即静脉注射0.5 ml稀释剂或待评估物质,此后每隔10分钟采集额外的血样(0.3 ml),持续2小时。注射高纯度绵羊PRL(500微克)可使血浆瘦素迅速升高,并在实验期间持续存在。较低剂量无效。为了确定阻断PRL分泌对瘦素分泌的影响,注射了α溴麦角隐亭(1.5毫克),一种能迅速抑制PRL释放的多巴胺-2-受体激动剂。它在10分钟内使血浆瘦素迅速下降,且下降持续120分钟。降低血浆瘦素的GH最小有效剂量为1毫克/只大鼠。胰岛素样生长因子(IGF-1)(10微克),而非IGF-2(10微克),也显著降低了血浆瘦素。已知在人类和大鼠中夜间释放的褪黑素,在白天(1100时)或夜间(2300时)以1毫克/只大鼠的剂量注射。它并未显著改变瘦素释放。地塞米松(DEX),一种强效糖皮质激素,0.1毫克剂量无效,但在注射1毫克剂量后100 - 120分钟出现延迟的、显著的瘦素升高。由于在人类中,当血浆瘦素浓度最高时,糖皮质激素在夜间会减少,我们推测相对高剂量的DEX导致的瘦素升高会模拟大鼠应激后皮质酮释放的反应,且糖皮质激素与瘦素浓度的昼夜节律无关。因此,我们得出结论,夜间PRL分泌增加可能至少部分导致了在大鼠和人类中观察到的夜间瘦素浓度升高。